Fuso Pharmaceutical Industries,Ltd. (TYO:4538)
Japan · Delayed Price · Currency is JPY 2,288.00
-27.00 (-1.17%)
Aug 25, 2026, 3:30 PM JST
TYO:4538 Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '13 Mar 31, 2013 | Mar '12 Mar 31, 2012 |
| 19,762 | 20,174 | 20,666 | 18,626 | 37,571 | 20,736 | |
Market Cap Growth | 5.05% | -2.38% | 10.95% | -50.42% | 81.19% | -7.68% |
Enterprise Value | 43,349 | 47,019 | 24,763 | 22,723 | 41,724 | 29,049 |
Last Close Price | 2315.00 | 2363.00 | 2347.46 | 2045.41 | 2848.52 | 1535.93 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '13 Mar 31, 2013 | Mar '12 Mar 31, 2012 |
PE Ratio | 9.02 | 10.03 | 7.43 | 13.53 | 7.71 | 55.74 |
Forward PE | - | 39.53 | 39.53 | 39.53 | - | - |
PS Ratio | 0.31 | 0.32 | 0.34 | 0.34 | 0.77 | 0.47 |
PB Ratio | 0.55 | 0.57 | 0.53 | 0.51 | 1.14 | 0.78 |
P/TBV Ratio | 0.57 | 0.60 | 0.55 | 0.52 | 1.15 | 0.78 |
P/FCF Ratio | - | - | - | - | 28.25 | - |
P/OCF Ratio | - | - | - | - | 11.53 | 23.46 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '13 Mar 31, 2013 | Mar '12 Mar 31, 2012 |
EV/Sales Ratio | 0.69 | 0.76 | 0.41 | 0.41 | 0.86 | 0.66 |
EV/EBITDA Ratio | - | 8.94 | - | - | 7.50 | 12.26 |
EV/EBIT Ratio | 14.37 | 17.80 | 5.99 | 11.56 | 10.93 | 60.39 |
EV/FCF Ratio | - | - | - | - | 31.37 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '13 Mar 31, 2013 | Mar '12 Mar 31, 2012 |
Debt / Equity Ratio | 0.79 | 0.90 | 0.66 | 0.62 | 0.40 | 0.51 |
Debt / EBITDA Ratio | - | 5.98 | - | - | 2.37 | 5.70 |
Debt / FCF Ratio | - | - | - | - | 9.94 | - |
Net Debt / Equity Ratio | 0.66 | 0.76 | 0.50 | 0.48 | 0.12 | 0.35 |
Net Debt / EBITDA Ratio | - | 5.06 | - | - | 0.74 | 3.89 |
Net Debt / FCF Ratio | - | -3.55 | - | - | 3.08 | -28.62 |
Asset Turnover | 0.72 | 0.74 | 0.78 | - | 0.73 | 0.73 |
Inventory Turnover | 3.05 | 3.03 | 3.02 | - | 4.27 | 4.66 |
Quick Ratio | 0.59 | 0.61 | 0.93 | 0.99 | 1.15 | 0.98 |
Current Ratio | 1.12 | 1.11 | 1.37 | 1.52 | 1.49 | 1.32 |
Return on Equity (ROE) | 6.36% | 5.42% | 7.34% | - | 16.32% | 1.41% |
Return on Assets (ROA) | 2.16% | 1.95% | 3.33% | - | 3.58% | 0.50% |
Return on Invested Capital (ROIC) | 4.04% | 3.62% | 5.38% | 3.35% | 8.17% | 1.37% |
Return on Capital Employed (ROCE) | 7.70% | 6.80% | 9.50% | 4.30% | 8.60% | 1.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '13 Mar 31, 2013 | Mar '12 Mar 31, 2012 |
Earnings Yield | 11.09% | 9.97% | 13.45% | 7.39% | 12.96% | 1.79% |
FCF Yield | -37.90% | -37.13% | - | - | 3.54% | -1.55% |
Dividend Yield | 3.91% | 3.81% | 3.49% | 3.42% | 2.11% | 3.91% |
Payout Ratio | - | 36.50% | - | - | 11.13% | 145.70% |
Buyback Yield / Dilution | 0.04% | 0.05% | 0.79% | 4.89% | 0.02% | 0.03% |
Total Shareholder Return | 3.96% | 3.85% | 4.28% | 8.32% | 2.12% | 3.93% |